Kenvue Inc

Kenvue CEO says consumers are spending on brand-name health products even as they pull back in other areas
Business

Kenvue CEO says consumers are spending on brand-name health products even as they pull back in other areas

Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, speaks during an interview to celebrate its IPO at the New York Stock Exchange (NYSE), May 4, 2023. Brendan Mcdermid | Reuters Most consumers have pulled back on spending as inflation squeezes their wallets, but they have not stopped paying up for brand-name […]

Read More
Johnson & Johnson investors can soon swap their shares for Kenvue stock — here’s what you need to know
Health

Johnson & Johnson investors can soon swap their shares for Kenvue stock — here’s what you need to know

Thibaut Mongon, CEO and Paul Ruh CFO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, pose together during the company’s IPO at the New York Stock Exchange (NYSE) in New York City, U.S., May 4, 2023. Brendan McDermid | Reuters Johnson & Johnson on Thursday said its shareholders will soon be able to swap […]

Read More
J&J’s strong quarter was amplified by new details around its big Kenvue consumer unit stake
Health

J&J’s strong quarter was amplified by new details around its big Kenvue consumer unit stake

Johnson & Johnson (JNJ) reported strong second – quarter profit and revenue before the opening bell Thursday, with better-than-expected results both domestically and internationally, as well as across all major operating segments. J & J’s second-quarter reported sales rose 6.3% year-over-year to $25.53 billion, exceeding the Refinitv consensus estimate of $24.63 billion. (On an adjusted […]

Read More
Kenvue earnings top estimates in J&J spinoff’s first quarterly report since IPO
Health

Kenvue earnings top estimates in J&J spinoff’s first quarterly report since IPO

Kenvue, a unit of Johnson & Johnson’s consumer health business. CFOTO | Future Publishing | Getty Images Kenvue reported second-quarter revenue and adjusted earnings that topped expectations Thursday in the consumer health company’s first quarterly report since it spun out from Johnson & Johnson two months ago. The company also issued an upbeat sales outlook […]

Read More
Johnson & Johnson beats on earnings, hikes full-year guidance as medtech sales surge
Health

Johnson & Johnson beats on earnings, hikes full-year guidance as medtech sales surge

Johnson & Johnson on Thursday reported second-quarter revenue and adjusted earnings that topped Wall Street’s expectations, and lifted its full-year guidance as sales from the company’s medtech business jumped. The medtech division provides devices for surgeries, orthopedics and vision. The company is benefitting from a rebound in demand for non-urgent surgeries among older adults, who […]

Read More
Tylenol parent Kenvue can capitalize on consumer self-care trends, JPMorgan says
Health

Tylenol parent Kenvue can capitalize on consumer self-care trends, JPMorgan says

Kenvue is well-positioned for accelerated growth following its separation from parent company Johnson & Johnson, according to JPMorgan. Following its spinoff earlier in May, Kenvue is the largest pure-play consumer health company in the world. The company holds commonly-known brands such as Neutrogena, Tylenol, Aveeno and Zyrtec — amounting to 10 brands with sales greater […]

Read More
Johnson & Johnson’s consumer health unit Kenvue started trading. What it means for J&J shareholders like us
Health

Johnson & Johnson’s consumer health unit Kenvue started trading. What it means for J&J shareholders like us

Johnson & Johnson ‘s (JNJ) consumer-health unit Kenvue (KVUE) soared more than 22% on its first day of trading Thursday, bringing the Club holding one step closer to completing its business separation. The planned split, which is set for later this year, is in the best interest of shareholders of both the soon-to-be-solo Kenvue operations […]

Read More
J&J’s consumer health spinoff Kenvue opens at .53, a 16% jump, in public market debut
Health

J&J’s consumer health spinoff Kenvue opens at $25.53, a 16% jump, in public market debut

Thibaut Mongon, CEO and Paul Ruh CFO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, pose together during the company’s IPO at the New York Stock Exchange (NYSE) in New York City, U.S., May 4, 2023. Brendan McDermid | Reuters Johnson & Johnson‘s consumer health spinoff Kenvue jumped 16% in its market debut on […]

Read More
J&J’s consumer health business Kenvue is going public this week. Here’s what to know
Business

J&J’s consumer health business Kenvue is going public this week. Here’s what to know

Johnson & Johnson products on a shelf in a store in New York. Lucas Jackson | Reuters Johnson & Johnson‘s consumer health business, Kenvue, is expected to go public this week in the largest U.S. IPO in more than a year.  That business is chock full of household names familiar to investors and the larger […]

Read More